3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35011738 | Targeting PGM3 as a Novel Therapeutic Strategy in KRAS/LKB1 Co-Mutant Lung Cancer. | 2022 Jan 5 | 1 |
| 2 | 33257855 | The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. | 2020 Dec | 1 |
| 3 | 24692660 | AMPK regulates histone H2B O-GlcNAcylation. | 2014 May | 1 |